SCHEMBL4757159

SCHEMBL4757159

Cc1ccc(C(=O)Nc2ncc(S(=O)(=O)c3ccccc3)s2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
MAPT P10636 3/20 0.53
POLB P06746 1/20 0.53
PKM P14618 1/20 0.53
ALDH1A1 P00352 4/20 0.51
CRHBP P24387 2/20 0.51
CRHR2 Q13324 2/20 0.51
CCNE1 P24864 1/20 0.50
CDK2 P24941 1/20 0.50
CDK5 Q00535 1/20 0.50
KDR P35968 1/20 0.50
RXFP1 Q9HBX9 4/20 0.49
NPSR1 Q6W5P4 2/20 0.49
TP53 P04637 1/20 0.49
ALOX15 P16050 1/20 0.49
PPARG P37231 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756932 0.87 MEN1 (0.59) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL10114538 0.85 KMT2A (0.55) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL4757155 0.83 NPC1 (0.59) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL10114338 0.81 MEN1 (0.53) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL4757983 0.79 KDR (0.61) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL233270 0.76 SMN1; SMN2 (0.75) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL17107103 0.76 KDR (0.81) MEN1KMT2ASMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL29287796 0.74 LOXL2 (0.56) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL4756596 0.74 CRHBP (0.66) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL1270133 0.73 SMN1; SMN2 (0.75) MEN1KMT2ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MEN1 4564/4885KMT2A 2303/4885SMN1; SMN2 3410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.